Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

359 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.
Van Lint MT, Uderzo C, Locasciulli A, Majolino I, Scimé R, Locatelli F, Giorgiani G, Arcese W, Iori AP, Falda M, Bosi A, Miniero R, Alessandrino P, Dini G, Rotoli B, Bacigalupo A. Van Lint MT, et al. Among authors: dini g. Blood. 1998 Oct 1;92(7):2288-93. Blood. 1998. PMID: 9746766 Free article. Clinical Trial.
Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
Uderzo C, Valsecchi MG, Bacigalupo A, Meloni G, Messina C, Polchi P, Di Girolamo G, Dini G, Miniero R, Locatelli F, et al. Uderzo C, et al. Among authors: dini g. J Clin Oncol. 1995 Feb;13(2):352-8. doi: 10.1200/JCO.1995.13.2.352. J Clin Oncol. 1995. PMID: 7844596 Clinical Trial.
Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.
Locatelli F, Zecca M, Rondelli R, Bonetti F, Dini G, Prete A, Messina C, Uderzo C, Ripaldi M, Porta F, Giorgiani G, Giraldi E, Pession A. Locatelli F, et al. Among authors: dini g. Blood. 2000 Mar 1;95(5):1572-9. Blood. 2000. PMID: 10688810 Free article. Clinical Trial.
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO).
Dini G, Cancedda R, Locatelli F, Bosi A, Bandini G, Alessandrino EP, Porta F, Uderzo C, Messina C, Fagioli F, Arcese W, Marenco P, Fanin R, Falda M, Soligo D, La Nasa G, Giardini C, Pession A, Scimè R, Di Bartolomeo P, Bruno B, Garbarino L, Lamparelli T, Giorgiani G, Lanino E, Manzitti C, Bacigalupo A; Italian Bone Marrow Transplant Group (GITMO). Dini G, et al. Haematologica. 2000 Nov;85(11 Suppl):30-6. Haematologica. 2000. PMID: 11268321
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO).
Dini G, Cancedda R, Locatelli F, Bosi A, Bandini G, Alessandrino EP, Porta F, Uderzo C, Messina C, Fagioli F, Arcese W, Marenco P, Fanin R, Falda M, Soligo D, La Nasa G, Giardini C, Pession A, Scimè R, Di Bartolomeo P, Bruno B, Garbarino L, Lamparelli T, Giorgiani G, Lanino E, Manzitti C, Bacigalupo A; Italian Bone Marrow Transplant Group (GITMO). Dini G, et al. Haematologica. 2001 May;86(5):451-6. Haematologica. 2001. PMID: 11410406 Free article.
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.
Crocchiolo R, Zino E, Vago L, Oneto R, Bruno B, Pollichieni S, Sacchi N, Sormani MP, Marcon J, Lamparelli T, Fanin R, Garbarino L, Miotti V, Bandini G, Bosi A, Ciceri F, Bacigalupo A, Fleischhauer K; Gruppo Italiano Trapianto di Midollo Osseo, Cellule Staminale Ematopoietiche (CSE) e Terapia Cellulare; Italian Bone Marrow Donor Registry. Crocchiolo R, et al. Blood. 2009 Aug 13;114(7):1437-44. doi: 10.1182/blood-2009-01-200378. Epub 2009 Jun 10. Blood. 2009. PMID: 19515726 Free article. Clinical Trial.
No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission.
Dini G, Zecca M, Balduzzi A, Messina C, Masetti R, Fagioli F, Favre C, Rabusin M, Porta F, Biral E, Ripaldi M, Iori AP, Rognoni C, Prete A, Locatelli F; Associazione Italiana Ematologia ed Oncologia Pediatrica–Hematopoietic Stem Cell Transplantation (AIEOP-HSCT) Group. Dini G, et al. Blood. 2011 Dec 15;118(25):6683-90. doi: 10.1182/blood-2011-05-354233. Epub 2011 Oct 18. Blood. 2011. PMID: 22010101 Free article.
359 results